Mylan, Inc. has acquired Merck KGaA’s Central and Eastern Europe (CEE) generics businesses, which include operations in Poland, Hungary, Slovakia, Slovenia and the Czech Republic. Mylan exercised its option to acquire these businesses as part of a previous agreement from October 2007 in which Mylan acquired Merck KGaA’s generics business (Merck Generics) in Western Europe, Asia-Pacific, Africa and North America.     “Our acquisition of the CEE businesses gives us access to a...